A genome-wide investigation of effects of aberrant DNA methylation on the usage of alternative promoters in hepatocellular carcinoma (vol 11, 780266, 2022)
Frontiers in oncology（2023）
摘要
The aberrant methylation status plays a critical role in the precision usage of APs in HCC, which sheds light on the mechanism of cancer development and provides a new insight into cancer screening and treatment.
更多查看译文
关键词
DNA methylation,alternative promoters,diagnostic model,hepatocellular carcinoma,survival prediction
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要